BMJ
- SHELTON J, Zotow E, Smith L, Johnson SA, et al
25 year trends in cancer incidence and mortality among adults aged 35-69 years in
the UK, 1993-2018: retrospective secondary analysis.
BMJ. 2024;384:e076962.
- WILKINSON E
Covid inquiry: What we have learnt about Wales's response?
BMJ. 2024;384:q608.
Clin Infect Dis
- SHRESTHA NK, Burke PC, Nowacki AS, Gordon SM, et al
Effectiveness of the 2023-2024 Formulation of the Coronavirus Disease 2019 mRNA
Vaccine.
Clin Infect Dis. 2024 Mar 11:ciae132. doi: 10.1093.
- ROWAN CM, LaBere B, Young CC, Zambrano LD, et al
Pre-existing Immunocompromising Conditions and Outcomes of Acute COVID-19
Patients Admitted for Pediatric Intensive Care.
Clin Infect Dis. 2024 Mar 11:ciae133. doi: 10.1093.
- ROMINE JK, Li H, Coughlin MM, Jones JM, et al
Hybrid immunity and SARS-CoV-2 antibodies: results of the HEROES-RECOVER
prospective cohort study.
Clin Infect Dis. 2024 Mar 11:ciae130. doi: 10.1093.
- HAYDEN MK, El Mikati IK, Hanson KE, Englund JA, et al
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19:
Serologic Testing.
Clin Infect Dis. 2024 Mar 15:ciae121. doi: 10.1093.
Infect Control Hosp Epidemiol
- NAKAGAWA M, Fujishiro Y, Doi Y, Yamakami J, et al
Differences in the incidence of nosocomial-onset COVID-19 among hospitalized
patients with exposure to SARS-CoV-2.
Infect Control Hosp Epidemiol. 2024 Mar 14:1-3. doi: 10.1017/ice.2024.
- LI H, Sewell DK, Herman T, Pemmeraju SV, et al
Comparing multiple infection control measures in a nursing home setting: a
simulation study.
Infect Control Hosp Epidemiol. 2024 Mar 15:1-8. doi: 10.1017/ice.2024.
Int J Infect Dis
- BANDA L, Ho A, Kasenda S, Read JM, et al
Characterizing the evolving SARS-CoV-2 seroprevalence in urban and rural Malawi
between February 2021 and April 2022: A population-based cohort study.
Int J Infect Dis. 2023;137:118-125.
- HOSOZAWA M, Hori M, Hayama-Terada M, Arisa I, et al
Prevalence and risk factors of post-coronavirus disease 2019 condition among
children and adolescents in Japan: A matched case-control study in the general
population.
Int J Infect Dis. 2024 Mar 12:107008. doi: 10.1016/j.ijid.2024.107008.
J Infect
- MORENO-TORRES V, Martinez-Urbistondo M, Calderon-Parra J, de Mendoza C, et al
COVID-19 Mortality Amongst the Immunosuppresed.
J Infect. 2024 Mar 11:106137. doi: 10.1016/j.jinf.2024.106137.
J Med Virol
-
Correction to "Exploring the impact of ursodeoxycholic acid therapy on COVID-19
in a real-word setting".
J Med Virol. 2024;96:e29518.
- ZHENG Y, Feng J, Song Y, Yu Y, et al
Design and synthesis of APN and 3CLpro dual-target inhibitors based on STSBPT
with anticoronavirus activity.
J Med Virol. 2024;96:e29512.
- ROJO-ALBA S, Martinez ZP, Gonzalez-Alba JM, Boga JA, et al
Respiratory syncytial virus incidence and typing in the last six seasons in the
north of Spain (Asturias). Genetic characterization during the SARS-CoV-2
pandemic.
J Med Virol. 2024;96:e29499.
- YEH LT, Chan CH, Wang YH, Lee CY, et al
Exploring the incidence of peripheral arterial occlusive disease following
COVID-19 infection: A retrospective cohort study.
J Med Virol. 2024;96:e29519.
- TAI CG, Haviland MJ, Kissler SM, Lucia RM, et al
Low antibody levels associated with significantly increased rate of SARS-CoV-2
infection in a highly vaccinated population from the US National Basketball
Association.
J Med Virol. 2024;96:e29505.
- LEE C, Greenwood DC, Master H, Balasundaram K, et al
Prevalence of orthostatic intolerance in long covid clinic patients and healthy
volunteers: A multicenter study.
J Med Virol. 2024;96:e29486.
J Travel Med
- QUIGLEY AL, Kunasekaran M, Stone H, Honeyman D, et al
The impact of the cruise ship coral princess on COVID-19 transmission in regional
Western Australia in 2022.
J Travel Med. 2024 Mar 12:taae044. doi: 10.1093.
J Virol
- LIU D, Cruz-Cosme R, Wu Y, Leibowitz J, et al
2-Bromopalmitate depletes lipid droplets to inhibit viral replication.
J Virol. 2024 Mar 15:e0017124. doi: 10.1128/jvi.00171.
- BABOT M, Boulard Y, Agouda S, Pieri L, et al
Oligomeric assembly of the C-terminal and transmembrane region of SARS-CoV-2
nsp3.
J Virol. 2024 Mar 14:e0157523. doi: 10.1128/jvi.01575.
- HEINDL MR, Rupp A-L, Schwerdtner M, Bestle D, et al
ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of
influenza A virus in airway cells.
J Virol. 2024 Mar 12:e0010224. doi: 10.1128/jvi.00102.
JAMA
- ANDERER S
CDC Recommends Additional COVID-19 Booster for Older Adults.
JAMA. 2024 Mar 13. doi: 10.1001/jama.2024.2071.
- MCKENZIE C, Moore L, Borthwick M
Vitamin C for Patients Hospitalized With COVID-19.
JAMA. 2024;331:886.
- ADHIKARI NKJ, Lamontagne F
Vitamin C for Patients Hospitalized With COVID-19-Reply.
JAMA. 2024;331:886-887.
- HARRIS E
Virtual Group Exercise Program Improved Long COVID Symptoms.
JAMA. 2024;331:822.
Lancet
-
Global age-sex-specific mortality, life expectancy, and population estimates in
204 countries and territories and 811 subnational locations, 1950-2021, and the
impact of the COVID-19 pandemic: a comprehensive demographic analysis for the
Global Burden
Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
- SHAWE-TAYLOR M, Greenwood D, Hobbs A, Dowgier G, et al
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster
campaign.
Lancet. 2024 Mar 11:S0140-6736(24)00316-7. doi: 10.1016/S0140-6736(24)00316.
- PARHIZ H, Atochina-Vasserman EN, Weissman D
mRNA-based therapeutics: looking beyond COVID-19 vaccines.
Lancet. 2024 Mar 7:S0140-6736(23)02444-3. doi: 10.1016/S0140-6736(23)02444.
Lancet Infect Dis
- ZHANG R, Hung IF
Bivalent (Omicron BA.5/ancestral) recombinant spike protein vaccine: a promising
booster.
Lancet Infect Dis. 2024 Mar 6:S1473-3099(24)00156.
- BENNETT C, Woo W, Bloch M, Cheung K, et al
Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2
recombinant spike protein vaccine as a heterologous booster dose: interim
analysis of a phase 3, non-inferiority, randomised, clinical trial.
Lancet Infect Dis. 2024 Mar 6:S1473-3099(24)00077.
- BILSEN MP, Conroy SP, Schneeberger C, Platteel TN, et al
A reference standard for urinary tract infection research: a multidisciplinary
Delphi consensus study.
Lancet Infect Dis. 2024 Mar 5:S1473-3099(23)00778.
MMWR Morb Mortal Wkly Rep
- YOUSAF AR, Lindsey KN, Wu MJ, Shah AB, et al
Notes from the Field: Surveillance for Multisystem Inflammatory Syndrome in
Children - United States, 2023.
MMWR Morb Mortal Wkly Rep. 2024;73:225-228.
Nature
- MERIGGI NF, Voors M, Levine M, Ramakrishna V, et al
Last-mile delivery increases vaccine uptake in Sierra Leone.
Nature. 2024 Mar 13. doi: 10.1038/s41586-024-07158.
- BUTTENHEIM A, Thirumurthy H
Mobile delivery of COVID-19 vaccines improved uptake in rural Sierra Leone.
Nature. 2024 Mar 13. doi: 10.1038/d41586-023-03186.
- KOZLOV M
Massive public-health experiment sends vaccination rates soaring.
Nature. 2024 Mar 13. doi: 10.1038/d41586-024-00730.
Science
- CROSS RW, Woolsey C, Chu VC, Babusis D, et al
Oral administration of obeldesivir protects nonhuman primates against Sudan
ebolavirus.
Science. 2024;383:eadk6176.
-
Erratum for the Research Article "The Huanan Seafood Wholesale Market in Wuhan
was the early epicenter of the COVID-19 pandemic" by M. Worobey et al.
Science. 2024;383:eadp1133.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016